Covered recipient · General Payments record
CAROLINE CAMILLE ROBICHAUX
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$799.58
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.13 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $97.77 | 4 |
| PFIZER INC. | $60.14 | 3 |
| Antares Pharma, Inc. | $22.79 | 1 |
| Neurocrine BioSciences, Inc. | $21.97 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.14 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.17 | 1 |
| Novo Nordisk AS | $14.16 | 1 |
| Acerta Pharma LLC | $13.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105958790 | CMS |
| ABBVIE INC. | $24.20 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105958792 | CMS |
| ABBVIE INC. | $20.38 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105958794 | CMS |
| ABBVIE INC. | $31.19 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105958796 | CMS |
| Antares Pharma, Inc. | $22.79 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146481708 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.99 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105364912 | CMS |
| Neurocrine Biosciences, Inc. | $21.97 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150851346 | CMS |
| Novo Nordisk Inc | $14.16 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096878008 | CMS |
| PFIZER INC. | $23.37 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223959 | CMS |
| PFIZER INC. | $20.14 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131441910 | CMS |
| PFIZER INC. | $16.63 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131071866 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.17 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153625343 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.14 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137663316 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.